These results reflect the complexity of the tumor itself and provide a straightforward explanation for a previous report by Taieb and colleagues[29] which showed KRAS mutations are independently related to poor prognosis in patients with MSS tumors. The gene discussed is KRAS; the disease is neoplasm.